Cambridge Investment Research Advisors, Inc. Medpace Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,745 shares of MEDP stock, worth $836,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,745
Previous 3,125
12.16%
Holding current value
$836,374
Previous $1.04 Million
12.56%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MEDP
# of Institutions
625Shares Held
25.8MCall Options Held
74.3KPut Options Held
79.1K-
Black Rock Inc. New York, NY2.58MShares$786 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$783 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA1.08MShares$331 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT937KShares$285 Million1.56% of portfolio
-
State Street Corp Boston, MA780KShares$238 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $9.48B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...